期刊文献+

合并感染性心内膜炎肥厚梗阻性心肌病的外科治疗 被引量:5

Surgical Treatment for Hypertrophic Obstructive Cardiomyopathy Complicated by Infective Endocarditis
原文传递
导出
摘要 目的探讨合并感染性心内膜炎的肥厚梗阻性心肌病(hypertrophic obstructive cardiomyopathy,HOCM)患者的手术方式及疗效。方法回顾性分析2006年9月至2012年2月阜外心血管病医院采用扩大Morrow手术+心内赘生物清除术+受累心瓣膜置换术治疗7例合并感染性心内膜炎HOCM患者的临床资料,其中男5例,女2例;年龄21~55(39.80±13.60)岁。术后观察手术疗效,比较手术前后的左心室流出道(LVOT)峰值压差、左心房内径、左心室射血分数和心功能。结果手术成功率100%,围术期无死亡。细菌性赘生物位于二尖瓣瓣叶7例、主动脉瓣瓣叶4例、室间隔1例;均为多发性,赘生物直径2~19 mm。血培养金黄色葡萄球菌生长3例、松鼠葡萄球菌生长1例。术后发生Ⅰ°房室传导阻滞2例、完全性左束支传导阻滞1例、左前分支传导阻滞2例,未予特殊处理。术后LVOT峰值压差、左心房内径均低于或小于术前;心功能较术前明显改善。7例患者均获得随访,随访时间1~49(13.00±17.19)个月,所有患者临床症状消失或明显减轻,生活质量明显改善,心功能分级(NYHA)Ⅰ~Ⅱ级,无再次手术或死亡。结论扩大Morrow手术+受累心瓣膜置换术治疗合并感染性心内膜炎HOCM患者,其早中期疗效满意。 Objective To analyze surgical procedures and clinical outcomes for patients with hypertrophic obstructive cardiomyopathy(HOCM) complicated by infective endocarditis.Methods We retrospectively analyzed clinical data of 7 patients with HOCM complicated by infective endocarditis who underwent modified Morrow procedure,removal of intracardiac vegetation,and valve replacement in Fu Wai Hospital from Sep.2006 to Feb.2012.There were 5 male patients and 2 female patients with their mean age of 39.80±13.60 years(ranging 21-55).Postoperative clinical outcomes were observed.Preoperative and postoperative left ventricular outflow tract(LVOT) gradients,left atrium(LA) diameter,left ventricular ejection fraction(LVEF) and heart function were compared.Results There was no in-hospital death and perioperative survival rate was 100% in this group.Bacteria vegetations were multiply detected on the mitral valve leaflet (7 cases),aortic valve leaflet(4 cases) and ventricular septum(1 case) with their diameter of 2-19 mm.Blood culture showed Staphylococcus aureus(3 cases),Squirrel aureus(1 case).Postoperatively,first-degree atrioventricular block occurred in 2 patients,complete left bundle branch block in 1 patient,left anterior division block in 2 patients,and all these complications were not treated.Postoperative LVOT gradient and LA diameter were significantly lower than preoperative values(P0.05),and cardiac function was significantly improved in these patients.All the patients underwent transthoracic echocardiography at a mean follow-up of 13.00±17.19(1-49) months in outpatient service.The clinical symptoms of all these patients were diminished or significantly ameliorated and their quality of life was considerably improved.All the patients had NYHA classⅠorⅡ without any reintervention or death during follow-up.Conclusion Modified Morrow procedure and valve replacement is a good surgical strategy for patients with HOCM complicated by infective endocarditis with satisfactory early and mid-term clinical outcomes.
出处 《中国胸心血管外科临床杂志》 CAS 2012年第6期597-601,共5页 Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
基金 首都卫生发展科研专项基金资助项目(2011-4003-05) 首都临床特色应用研究(Z121107001012017)~~
关键词 肥厚梗阻性心肌病 感染性心内膜炎 扩大Morrow手术 二尖瓣置换术 主动脉瓣置换术 Hypertrophic obstructive cardiomyopathy Infective endocarditis Modified Morrow procedure Mitral valve replacement Aortic valve replacement
  • 相关文献

参考文献4

二级参考文献38

  • 1Elliott P, McKenna WJ. Hypertrophic cardiomyopathy. Lancet, 2004,363 : 1881- 1891.
  • 2Brown ML, Schaff HV. Surgical management of obstructive hypertrophic cardiomyopathy: the gold standard. Expert Rev Cardiovasc Ther,2008 ,6 :715-722.
  • 3Sorajja P, Valeti U, Nishimura RA,et al. Outcome of alcohol se ptal ablation for obstructive hypertrophic cardiomyopathy. Circulation,2008,118 : 131-139.
  • 4Vural AH, Tiryakioglu O, Turk T, et al. Treatment modalities in hypertrophic obstructive cardiomyopathy: surgical myectomy versus percutaneous septal ablation. Heart Surg Forum, 2007,10 : 493- 497.
  • 5Maron BJ. Controversies in cardiovascular medicine. Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy. Circulation ,2007,116 : 196-206.
  • 6Monteiro PF, Ommen SR, Gersh B J, et al. Effects of surgical septal myectomy on left ventricular wall thickness and diastolic filling. Am J Cardiol,2007,100 : 1776-1778.
  • 7Maron BJ. Hypertrophic cardiomyopathy, a systematic review. JAMA, 2002,287,1308-1320.
  • 8Elliott PM, Gimeno JR, Thaman R, et al. Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy. Heart, 2006, 92(6):785-791.
  • 9Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA, 2002, 287(10 ):1308 1320.
  • 10Elliott P, McKenna WJ. Hypertrophic cardiomyopathy. Lancet, 2004, 363(p424): 1881-1891.

共引文献16

同被引文献45

  • 1侯晓彤,孟旭,白涛,陈宝田,周其文,王坚刚.≥65岁老年人心脏瓣膜病的外科治疗[J].中华胸心血管外科杂志,2005,21(6):325-327. 被引量:24
  • 2王巍,马维国,孙寒松,宋云虎,王水云,胡盛寿.肥厚型梗阻性心肌病合并冠心病的外科治疗效果[J].中国循环杂志,2007,22(4):296-298. 被引量:3
  • 3Morgan LB, Hartzell VS,Joseph AD,et al. Relationship between left ventricular mass, wall thickness, and survival after subaortic septal myectomy for hypertrophic obstructive cardiomyopathy [ J ]. J Thor Cardiov Surg,201 l, 141 (2) :439 - 443.
  • 4Raphael P,Jacques Q ,Thomas C, et al. Delayed occurrence of com- plete heart block after ethanol septal ablation for hypertrophic ob- structive cardiomyopathy [ J ]. Inter J Cardiol, 2011 , 147 ( 2 ) : 32 - 34.
  • 5Sherif FN,Bertron MG,Leonard S,et al. Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy: A Mohi- center North American Registry[J]. J Am College Cardiol,2011,58 (22) :2322 -2328.
  • 6Maron BJ, McKenna WJ, Danielsnn GK, et al. American college of cardiology/european society of cardiology clinical expert consensus document on hypertrophic eardiomyopathy. A report of the American Cnllege of Cardiology Foundation Task Force on Clinical Experl Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J, 2003, 24: 1965-1991.
  • 7Gersh B J, Maron BJ, Bonow RO, et, al. 2011 ACCF/AHA Guideline for the diagnosis and treatment of hypertrophie cardiomyopathy: Executive summary: A Report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. Circulation, 2011, 124:2761-2796.
  • 8Theis JL, Bos JM, Theis JD, et, al. Expression patterns of eardiac myofilament proteins: genornic and protein analysis of surgical myeetomy tissue from patients with obstructive hypertrophic cardiomyopathy. Cire Heart Fail, 2009, 2: 325-333.
  • 9Maron BJ, Olivotto I, Spirito P, et al. Epidemiology of hypertrophic, ardiomyopathy-related death revisited in a large non-referral-based patient population. Circulation, 2000, 102: 858-864.
  • 10Maron BJ. Controversies in cardiovascular medicine. Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopalhy. Circulation, 2007, 116: 196-206.

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部